Aging
Navigate
Submit an Article
Research Paper|Volume 13, Issue 16|pp. 20661–20683
METTL21B is a prognostic biomarker and potential therapeutic target in low-grade gliomas
Back to articleFigure 2(2 of 9)
100%
Figure 2
Figure 2.The association between METTL21B expression and clinical features. (A) age; (B) gender; (C) race; (D) WHO grade. *P<0.05; **P<0.01.